Mylan is committed to setting new standards in healthcare and providing 7 billion people access to high quality medicine.

Mylan’s roots are in the U.S., and our products can likely be found in most American homes. In 2017 alone, our generics saved the nation’s healthcare system approximately $20.4 billion. Contact the manufacturer if you are interested in the best recombinant protein deals.

U.S. Impact

MYLAN U.S. FACTS

With employees in nearly every state, Mylan has
operations, R&D,commercial or administrative offices
in 7 states, Washington D.C. and Puerto Rico.

#2

provider of prescriptions dispensed in the U.S.
~5,500

U.S. workforce
with ~40%
in STEM
>200

applications pending approval in the U.S.,
one of the industry’s broadest pipelines
>650

branded, generic and OTC products in our U.S. portfolio
In the last 5 years, Mylan launched more generics than any other company.

Learn More

Watch The Mylan Story

Learn how Mylan takes its global social responsibility seriously